Cannabis
Hemp, Inc. Announces Year-to-Date Milestones, Highlights and Pending Developments
Las Vegas, NV, April 30, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, including the 85,000 square foot multipurpose industrial hemp processing facility on 9 acres in Spring Hope, NC, a 55,000 square foot state-of the art local processing center in White City, Oregon, a 500-acre hemp growing Veteran Village Kins Community in Golden Valley, Arizona, two model “Small Family Hemp Farms” in North Carolina and Arizona, a pre-roll blending manufacturing facility in Las Vegas, NV, and a 5,000 square-foot retail store (The King of Hemp Store™) in Kingman, Arizona, announced today exactly how its revenues are flowing in from every direction. That is no surprise considering Hemp, Inc. has built a broad-based multi-state U.S. infrastructure over the last 10 years.
“We’ve made great strides this year so far and we’re expecting 2020 to be the biggest year of revenues for Hemp, Inc. The Company has consistently been a leader in the hemp industry, shaping what the industrial hemp industry will look like in the future,” said Bruce Perlowin, CEO of Hemp, Inc. “This year we are leaning into the growing demand for CBG for its highly acclaimed and diverse medicinal qualities, and industrial hemp to supply the growing demand for sustainable industrial materials.”Hemp, Inc.’s 2020 Top Revenue Highlights and Events to date include:Drillwall™ ProductAt the end of 2019, Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC (IHM) in North Carolina, signed a contract to supply $1,000,000 worth of its DrillWall™, a proprietary kenaf-hemp blend natural Loss Circulation Material (LCM) product for the oil and gas well drilling industries. To date, $120,000 of product has been delivered and paid for by the buyer.To read more regarding this lucrative deal, click here to read the press release “Hemp, Inc.’s North Carolina Operation Enters $1 Million Sales Agreement for Proprietary Loss Circulation Material Product, DrillWall”.The Great American HempathonThe Company’s first ever grow contest, The Great American Hempathon, also opened enrollment. During Hempathon, hemp growers can demonstrate their growing skills and share in the $50,000 prize money. The area for the Hempathon is situated on the 500-acre ecovillage, with 80+ acres designated for hemp cultivation. Each team is responsible for installing irrigation systems, preparing the soil, and maintaining the grow operation.There are currently 6 geodesic domes situated on the land as well as overnight RV camping sites so that participants can reside there during the grow. Hemp, Inc.’s Hemp Academy in Arizona will offer classes in one of the geodesic domes during the Hempathon. The programming is set to include lectures from hemp experts, product developers, field trips to the grow area, as well as movies, documentaries and courses on everything from biodynamic farming, permaculture, organic farming practices, bees and predator pest control, soil amendments, cloning, and grafting. The educational experience provides attendees with the opportunity to learn about this new emerging multi-billion dollar industry from hemp industry experts.To inquire about participating in the Hempathon, click here. To watch the “The Great American Hempathon” in real time, click here. The King of Hemp StoreTMThis year marked the soft launch of The King of Hemp Store™, Hemp, Inc.’s flagship, brick-and-mortar 5,000 square foot retail store in Kingman, Arizona. The store is expected to officially open soon.According to executives, The King of Hemp StoreTM will carry Hemp, Inc.’s King of HempTM (KOH) pre-roll line, a variety of cannabidiol CBD and CBG products such as flower, tinctures, health and beauty products, and apparel that includes hemp shirts, pants, hemp denim jeans, jackets, backpacks, purses, and handbags. Other items will include topicals, shampoos, conditioners and more. A lounge area in which community members can learn more about hemp, in a relaxing setting, is also planned as part of the store.The proceeds from the sale of its products will go to help orphans, the homeless and veterans. The plan is to utilize money earned at the store to create activities and subsequent venues for the children of Kingman, Golden Valley, and Dolan Springs, Arizona.To read the full release “Hemp, Inc.’s Newly Launched Retail Store in Kingman, Arizona Featured In Local Media Outlet Kingman Daily Miner”, click here.King of Hemp™ Pre-RollsThe King of Hemp™ (KOH) super-premium quality pre-roll line is in full production and bringing in revenue. The much anticipated pre-roll line didn’t disappoint once it launched as distributors reported quick sales in a matter of hours after stocking the high-quality CBD smokables. One distributor, in particular, sold almost 300 King of Hemp™ pre-rolls in a week after listing it on its website, www.naturalexposurecbd.com, and noticed a huge interest for autographed King of Hemp pre-rolls from the King of Hemp™ himself, Bruce Perlowin. Based on the interest, Perlowin expects the current limited edition (signed and numbered) to be extremely valuable in the collector’s market in the future. The Company is also transitioning from the current packaging to more sustainable packaging. Derived from one of the top selling cultivars on the market, Pre-98 OG Bubba Kush, the King of Hemp™ pre-rolls are already positioned to corner the market as one of the best tasting for hemp consumption and is expected to be a massive revenue generator for the company.Read “King of Hemp™ Pre-Rolls Capture Market and Garners Rave Reviews within One Day of Launching”. Visit KOH’s website www.kingofhempusa.com.King of Hemp™ FlowerThe first sales of KOH super-premium flower were made and continue to steadily grow. Though there was a slight interruption in sales due to the COVID-19 pandemic, sales have resumed and are on track.The Pre-98 OG Bubba Kush is Hemp, Inc.’s top-shelf CBD flower sourced from certified growers to ensure high CBD content, eye-popping aesthetics, and clean genetics. The company is selling 10,000 lbs. of Pre-98 OG Bubba Kush available for sale at a wholesale pricing. The rest of the grow will be used for the King of Hemp™ pre-rolls mentioned above which is expected to earn the Company more than three times as much money as selling it wholesale.Hemp, Inc. expects to roll-out the second product in the KOH product line -‘Midnight Express’ – in honor of Billy Hayes who made the name famous in the 1978 movie ‘Midnight Express’ chronicling his suffering at the hands of Turkish authorities for trying to smuggle hash shish out of Turkey, says Perlowin.Those interested in purchasing Hemp, Inc.’s hemp buds, email [email protected].King of Hemp™ TincturesKing of Hemp™ (KOH) Tinctures also hit the market with steady sales. There was a slight interruption in sales due to the COVID-19 pandemic but sales have resumed and are back on track. It’s also important to note that related COVID-19 issues delayed a nationwide roll-out but the Company is moving forward in selected areas.Events to note include:The Golden Grow AwardsThe Golden Grow Awards were held in conjunction with the Hemp University’s New Leaf Symposium. The sold-out event in January was held in Jacksonville, Oregon. It was an incredible experience for local farmers to get together and share ideas and strategies as they further their investment in this new industry. The event was an invaluable tool for anyone looking to grow hemp and to ensure the success of their farms. The New Leaf Symposium’s focus was “Regeneration” to celebrate optimism and resilience in the industry, the power of the plant, and faith in the hemp-producing community. The Golden Grow Awards Gala honored Oregon’s top cultivars and put Oregon’s best farmers head-to-head for some of the most prestigious hemp-industry accolades. There were four categories judged in the awards: Top CBD, Top Terpenes, Judge’s Favorite, and Peoples’ Choice.Ten growers from six states (Arizona, Nevada, California, North Carolina, Oregon, West Virginia) were selected to grow various CBG cultivars to determine the quality and strength of the cultivars in different microclimates.Read Hemp, Inc. Subsidiary, The Hemp University, Announces Successful New Leaf Symposium, Golden Grow Awards Gala for more information on The Golden Grow Awards.Cloning OperationsCloning operations are now underway in Arizona and North Carolina. This will help fill the void of CBG seeds expected this year, which are in high demand. The seeds will continue to be planted at various times of the year to determine suitability by cultivars in the tested microclimate. Last year, two cultivars that were extremely successful in Southern Oregon were tested and Hemp, Inc. grows in North Carolina. The results showed that growing in Oregon yields robust, high-quality plants. Growing microclimate specific cultivars dramatically increases yield and quality.Kins Community Website LaunchedHemp, Inc.’s Kins Community website (www.kinscommunity.com) was released to increase awareness of the problems many U.S. Veterans face today as well as a place for healing and growing for veterans.Read Hemp, Inc.’s Strategic Hemp Growing Partner Veteran Village Kins Community Arizona, Inc. Featured In The Kingman Daily Miner.King of Hemp™ Website to be RedesignedThe KOH website (http://www.kingofhempusa.com/) will be redesigned over the next few weeks for better functionality.The global industrial hemp market size is expected to reach USD 15.26 billion by 2027, exhibiting a revenue-based CAGR of 15.8% over the forecast period, according to a new report published by Grand View Research, Inc., citing a growing preference for eco-friendly products. Meanwhile, one of the key phytocannabinoids present in feminized hemp, CBG has been attracting a lot of attention in the scientific community for its many anti-inflammatory and anti-bacterial properties.For those interested in becoming a distributor for Hemp, Inc.’s King of Hemp™ pre-roll line, please email [email protected]. According to Perlowin, the Company will also offer an affiliate program for the pre-roll line. Those interested in becoming an affiliate should email [email protected].To see 1-minute videos of Hemp, Inc.’s current activities, go to Bruce Perlowin’s personal Facebook page where he posts daily on all of Hemp, Inc.’s activities around the country.WHAT IS HEMP, INC.?What is Hemp, Inc.? With a deep-rooted social and environmental mission at its core, Hemp, Inc. seeks to build a business constituency for the American small farmer, the American veteran, and other groups experiencing the ever-increasing disparity between tapering income and soaring expenses. As a leader in the industrial hemp industry with ownership of the largest commercial multi-purpose industrial hemp processing facility in North America, Hemp, Inc. believes there can be tangible benefits reaped from adhering to a corporate social responsibility plan.HEMP, INC.’S TEN DIVISIONSHemp, Inc. has been helping to build the industrial hemp infrastructure that was basically non-existent in America. There are now ten divisions:Division One – The Industrial Hemp InfrastructureDivision Two – The Hemp Farming InfrastructureDivision Three – The Hemp Extraction & Pre-Roll Blending InfrastructureDivision Four – The Hemp Educational InfrastructureDivision Five – The Hemp Marketing InfrastructureDivision Six – Accessories, Products and ServicesDivision Seven – Research and DevelopmentDivision Eight – Industrial Hemp Investments and Joint VenturesDivision Nine – Industrial Hemp ConsultingDivision Ten – Educational EntertainmentDivision One – The Industrial Hemp InfrastructureThe Industrial Hemp Infrastructure (Division One) currently consists of two hemp processing facilities across the country, with two more under development, which will include an in-house third party testing laboratory. The largest of the two is its multi-purpose industrial hemp processing facility and milling operation in Spring Hope, North Carolina. It’s the largest “industrial hemp processing center” in the western hemisphere and has grown to become one of the pre-eminent centers of the industrial hemp industry. The 85,000 square foot facility sits on 9-acres. It is environmentally sustainable and was built from the ground up in hopes of “Making America Hemp Again.” With a patent pending manufacturing process, the North Carolina facility is operating full time to process millions of pounds of our unique kenaf-hemp blend, to manufacture all-green natural loss circulation material (LCMs), called DrillWall™ that is to be sold to the oil and gas drilling industry, along with an all-green natural oil spill absorbent, a second industrial kenaf-hemp product called Spill-Be-Gone™.In addition to the company’s industrial hemp processing facility in Spring Hope, North Carolina, Hemp, Inc. also has one of the most sophisticated local processing centers (LPC) in Medford, Oregon which focuses on hemp harvesting, drying, curing, trimming, bagging, storing, and in some cases selling high CBD hemp for local farmers and the Company’s own hemp grows in that area, and post processing for the CBD industry. The Company’s main focus is the “King of Hemp™” pre-rolls and high CBD smokable buds… a new phenomenon of smoking hemp which has caught the marketplace by storm.Hemp, Inc., through its joint venture associates has access to 4,500 acres of land in Golden Valley, Arizona (100 miles from Las Vegas, 20 miles north of Kingman, AZ). Out of the 4,500 acres of land, 500 acres are designated for the Veteran’s Village Kins Community (VVKC) for Arizona. Hemp, Inc. is preparing 80+ acres, of the 500 acres, for hemp cultivation. The company aims to boost the economies of these towns by offering affordable hemp processing services, which incentivizes local growers to add hemp to their crop rotation. The company is continuing to scout new locations for local processing centers in Florida, Kentucky, West Virginia, Puerto Rico, and several other states.Thus far, Hemp, Inc.’s Local Processing Center (LPC) in Oregon has employed over 200 employees during its 2018 harvest season and over 300 employees during its 2019 harvest season to further support the infrastructure necessary for local and large scale farmers operating in the industrial hemp space.Division One Products:· DrillWall™ (a loss circulation material)· Spill-Be-Gone™ (an oil spill cleanup product)· Hemp bioplasticsDivision Two – The Hemp Farming InfrastructureThe Hemp Farming Infrastructure (Division Two) consists of hundreds of acres of hemp and kenaf growing in multiple locations, farm equipment, cloning rooms, clones and seeds, grow rooms, greenhouses, hemp drying facilities and a huge amount of peripheral farming tools and equipment. The progress Hemp, Inc. has made in its agricultural endeavors, over the course of four years, has been amazing. The year 2020 marks the fifth year that Hemp, Inc. has been growing hemp. (To see Hemp, Inc.’s agricultural progress from 2016 through 2019, visit Bruce Perlowin’s personal Facebook page at www.facebook.com/kingofpot and scroll through posts from 2016 to the present. Visit www.hempincpresents.com to see the videos of Hemp, Inc.’s grows in multiple locations.)Hemp, Inc. also has two “Small Family Hemp Farm” models. The “Small Family Hemp Farm” in North Carolina is situated on 12 acres and consists of a cloning room, a greenhouse, and enough land to grow 2,000-3,000 high CBD hemp plants. (This model farm can be seen on Bruce Perlowin’s Facebook page, in the Aug. 22nd – 26th, 2018 posts.) The model shows farmers how to grow high CBD hemp plants, operate a greenhouse and turn a barn into a cloning room to earn up to $100,000+ a year. This shows an example of how the “Small Family Hemp Farm” can be duplicated and reappear on the American landscape. After all, the original small family farms in America were able to survive economically by growing hemp as their main cash crop and the first five presidents of the United States were all hemp farmers.Hemp, Inc.’s other “Small Family Hemp Farm” is located Dolan Springs, Arizona. This “Small Family Hemp Farm” is referred to as “The Orchard” since it has a sizable organic orchard. There are: 2 acres on which hemp will be grown on; a cloning room; cold storage; and greenhouses that are currently being installed.This year, according to Perlowin, the company is preparing to grow on up to 342 acres of land in Oregon, 300 acres in Arizona, hundreds of acres in North Carolina (a combination of hemp and kenaf), and an undetermined amount in other states. He says collective sales from all of these grows will be extremely significant in terms of pre-rolls, high CBD buds, distillate, isolate and biomass. “This year, we anticipate the main function of the company to be sales and marketing as we will have completed the infrastructure to support sales and marketing. Right now, I believe we have the largest footprint of bio-diverse hemp products with vertical integration in the hemp industry in America today. We are always looking for joint ventures where we have or can expand our footprint,” commented Perlowin.Moreover, “A to Z” services for the farmers are available – from harvesting to drying, curing, bucking, machine trimming, hand trimming, bagging, storing, nitrogen sparging, and selling… creating a “one stop shop” for the small to large family farms.Division Two Products:· The King of Hemp™ Pre-Roll Blends· High premium CBD buds from the Rogue Valley in Southern Oregon, North Carolina and ArizonaHemp, Inc. is also hosting the Hempathon at the Veteran Village Kins Community in Arizona. Contestants are growing 1 acre of hemp in a contest with other growers from around the country. Hemp, Inc. is providing land, water, security, and live streaming video coverage for participants. The Hempathon entry fee is $5,000 and a 50/50 revenue split. Several awards and prizes will be given to the winners. Those interested in signing up for the Hempathon should contact Stacey Theis at [email protected].Division Three – The Hemp Extraction & Pre-Roll Blending InfrastructureThe Hemp CBD Oil Extraction & Pre-Roll Blending Infrastructure (Division Three) originally consisted of a Supercritical C02 Extractor. After operating for over a year it has been determined that Hemp, Inc. will not be involved in the extraction industry and has changed its direction to focus primarily on the King of Hemp pre-rolls and The King of Hemp high CBD smokable flower. The CBD oil that was extracted from the 2018 hemp grows in North Carolina has been made into pure crystalline CBD isolate which will add to our “King of Hemp™” branded line of pre-rolls to take to the marketplace and a pre-roll fortified with pure crystalline CBD isolate.In lieu of building its own extraction laboratories, Hemp, Inc. plans to utilize the facilities of other labs in the industry to manufacture its own line of CBD oil products while they continue to build and expand the infrastructure for pre-rolls and high CBD smokable buds. The Company will hire or joint venture with other, already existing, labs to manufacture CBD, CBG, CBC, CBN, and other products in its future cannabinoid line. With 150 different cannabinoids, over 300 terpenes, and more of each being discovered almost monthly, the product range and possibilities in this area are endless.Division Four – The Hemp Educational InfrastructureThe Hemp Educational Infrastructure (Division Four) includes Hemp, Inc.’s Hemp University which focuses on educating and empowering Hemp farmers and entrepreneurs with knowledge, processing, infrastructure and support. The educational seminars, through the Hemp University, are held periodically and teach farmers and landowners how to create a profitable income stream by maximizing the per-acre crop revenue. Through this division, Hemp, Inc. has trained well over 500 farmers in its first two years by doing a total of nine Hemp University seminars in North Carolina and Oregon, thus far, which include:The New Leaf Symposium and Golden Grow Awards Gala – January 26, 2020 (Jacksonville, Oregon)
Cannabis
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors
TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ — IM Cannabis Corp. (“IMC” or the “Company“) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company’s board of directors (the “Board“) effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company’s commitment to driving growth while focusing on sustainable profitability.
“We are thrilled to welcome Shmulik to our Board of Directors,” said Oren Shuster, Chief Executive Officer of IM Cannabis. “Shmulik’s extensive international experience at Leumi, coupled with his proven track record in banking and finance will be invaluable as we continue to deliver on our strategic initiatives.”
Mr. Arbel retired as Deputy CEO from Leumi, Israel’s largest banking group, in April 2023, where he was instrumental in business growth and leading the service revolution. With over 25 years of experience at Leumi, Arbel has held senior roles throughout the organization, such as head of retail banking, head of the corporate division, and as chairman of Leumi UK. With key roles in Israel, New York and London, Mr. Arbel has a wide view on international business.
“I am honored to join the Board of Directors at IMCC,” said Mr. Arbel. “I look forward to leveraging my experience in banking and finance, providing guidance as IMCC continues to establish itself as the go-to brand in the cannabis world. I look forward to contributing to the company’s growth.”
Arbel holds a BA and MBA from Tel Aviv University.
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.
Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, “forward-looking statements“). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to: the stated benefits Mr. Arbel’s appointment, including the further strengthening the Company’s commitment to driving growth in the German market while focusing on sustainable profitability; and Mr. Arbel’s international experience and track record in banking and finance will be invaluable to the Company.
Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the Company’s ability to realize upon the stated benefits Mr. Arbel’s appointment; and Mr. Arbel’s international experience and track record in banking and finance becoming invaluable to the Company.
The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and its subsidiaries (collectively, the “Group“) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the Israel-Hamas war on the Company, its operations and the medical cannabis industry in Israel; risks associated with the Company focusing on the Israel and Germany markets; the inability of the Company to achieve sustainable profitability and/or increase shareholder value; the inability of the Company to actively manage costs and/or improve margins; the inability of the company to grow and/or maintain sales; the inability of the Company to meet its goals and/or strategic plans; the inability of the Company to reduce costs and/or maintain revenues; the Company’s inability to take advantage of the legalization of medicinal cannabis in Germany; and the Company’s inability to realize upon the stated benefits Mr. Arbel’s appointment; and Mr. Arbel’s international experience and track record in banking and finance not becoming valuable to the Company.
Please see the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report dated March 28, 2024, which is available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]
Oren Shuster, CEO
IM Cannabis Corp.
[email protected]
Logo: https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/im-cannabis-announces-appointment-of-shmulik-arbel-to-board-of-directors-302244961.html
Cannabis
One World Products Issues Shareholder Update Letter
Cannabis
Europe Medical Cannabis Market Forecast 2024-2032: Tilray, Aurora Cannabis, and GW Pharmaceuticals Dominate the Market Landscape
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) — The “Europe Medical Cannabis Oil Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2024-2032.” report has been added to ResearchAndMarkets.com’s offering.
The Europe Medical Cannabis Oil market is poised for significant growth, projected to escalate from US$ 0.91 billion in 2023 to US$ 2.40 billion by 2032, advancing at a CAGR of 12.08%. In this comprehensive research report, the market is analyzed by:
- Derivatives;
- Source;
- Application;
- Route of Administration;
- End-user;
- Distribution Channel; and
- Country.
Market Highlights Identified in the Report
- Progressive legalization across Europe is creating a favorable regulatory environment, enhancing market expansion for medical cannabis oil products.
- Germany leads the market with a robust infrastructure and supportive regulations, while other countries like the UK, Italy, and Spain show significant growth potential based on evolving regulatory landscapes and market dynamics.
- Key players such as Tilray, Aurora Cannabis Inc., and GW Pharmaceuticals dominate the market, emphasizing research, strategic partnerships, and innovation to maintain competitive edge amidst evolving industry dynamics.
The medical cannabis oil market has experienced substantial growth as legalization and acceptance of cannabis-based treatments expand globally. Cannabis oil, derived from the cannabis plant through extraction methods, contains cannabinoids such as THC and CBD, known for their therapeutic properties. Increasing recognition of cannabis oil’s potential in alleviating symptoms of various medical conditions, including chronic pain, epilepsy, and anxiety disorders, has driven its adoption in medical settings.
Governments in several countries are progressively legalizing medical cannabis, creating a conducive regulatory environment for market expansion. Additionally, growing consumer awareness about alternative and natural therapies has fueled the demand for cannabis oil products. The market is characterized by diverse product offerings, including full-spectrum and CBD-isolate oils, catering to different therapeutic needs and preferences.
Despite regulatory challenges and stigma associated with cannabis, the medical cannabis oil market continues to evolve, driven by ongoing research, favorable legislative changes, and shifting attitudes toward cannabis-based therapies in healthcare.
Regional Insights
Germany is likely to maintain its leadership position in the European medical cannabis oil market due to its established infrastructure, supportive regulations, and strong healthcare system. Germany legalized medical cannabis in 2017, giving the market a head start compared to many other European countries. This established infrastructure and experience position Germany as a leader in the field. As awareness and acceptance of medical cannabis increase, the number of patients seeking treatment in Germany is steadily rising. This fuels market growth and incentivizes further investment in research and development.
Germany’s regulatory framework for medical cannabis is considered relatively patient-friendly compared to some other European countries. This facilitates access for patients with qualifying conditions. The UK legalized medical cannabis in 2018 and is experiencing an increase in patient access programs. This, coupled with ongoing research, could lead to significant market growth. Italy legalized medical cannabis in 2006 but has faced challenges with availability. As regulations become more streamlined and patient access expands, the Italian market holds significant growth potential. Spain has a well-established medical cannabis industry with a focus on domestic production. As regulations evolve and export opportunities increase, the Spanish market could see a boost.
Competitive Landscape
The Medical Cannabis Oil market is characterized by a vigorous competitive landscape, with prominent entities like Tilray, Aurora Cannabis Inc., GW Pharmaceuticals, Almiral, Bedrocan, and others at the forefront, collectively accounting for approximately 41 % of the overall market share. This competitive milieu is fueled by their intensive efforts in research and development as well as strategic partnerships and collaborations, underscoring their commitment to solidifying market presence and diversifying their offerings.
The primary competitive factors include pricing, product caliber, and technological innovation. As the Medical Cannabis Oil industry continues to expand, the competitive fervor among these key players is anticipated to intensify. The impetus for ongoing innovation and alignment with evolving customer preferences and stringent regulations is high. The industry’s fluidity anticipates an uptick in novel innovations and strategic growth tactics from these leading corporations, which in turn propels the sector’s comprehensive growth and transformation.
Key Topics Covered
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 3. Executive Summary: Europe Medical Cannabis Oil Market
Chapter 4. Europe Medical Cannabis Oil Market Overview
Chapter 5. Europe Medical Cannabis Oil Market Analysis, by Derivatives
Chapter 6. Europe Medical Cannabis Oil Market Analysis, by Source
Chapter 7. Europe Medical Cannabis Oil Market Analysis, by Application
Chapter 8. Europe Medical Cannabis Oil Market Analysis, by Route of Administration
Chapter 9. Europe Medical Cannabis Oil Market Analysis, by End-user
Chapter 10. Europe Medical Cannabis Oil Market Analysis, by Distribution Channel
Chapter 11. Europe Medical Cannabis Oil Market Analysis, by Country
Chapter 12. The UK Medical Cannabis Oil Market Analysis
Chapter 13. Germany Medical Cannabis Oil Market Analysis
Chapter 14. The Netherlands Medical Cannabis Oil Market Analysis
Chapter 15. Italy Medical Cannabis Oil Market Analysis
Chapter 16. Spain Medical Cannabis Oil Market Analysis
Chapter 17. Poland Medical Cannabis Oil Market Analysis
Chapter 18. Rest of Europe Medical Cannabis Oil Market Analysis
Chapter 19. Company Profiles (Company Overview, Financial Matrix, Key Product Landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurora Cannabis Inc.
- Bedrocan
- Biocann
- BIOTA Biosciences LLC
- Cannamedical
- Mary Jane CBD
- Sanity Group GmbH
- Tilray
- Valcon Medical
For more information about this report visit https://www.researchandmarkets.com/r/dh7q46
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
-
Indivior2 weeks ago
Indivior Provides Update on Aelis Farma’s Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder
-
Cannabis1 week ago
One World Products Issues Shareholder Update Letter
-
Cannabis1 week ago
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors